JohnContiMD

PubMed

• 15 citations
  Non-Melanoma Skin Cancers in the Older Patient.
  Ashley Albert, Miriam A. Knoll, John A. Conti, Ross I S Zbar> ;Current Oncology Reports. 2019 Jul 29
• 8 citations
  A Rare Case of Grey Zone Lymphoma Successfully Treated with Brentuximab Vedotin and R-CHP Chemotherapy
  Rajiv M. Mallipudi, Lance Alquran, Vishnu A. Shenoy, Lori A. Leslie, John A. Conti> ;Case Reports in Oncological Medicine. 2019 Apr 11
• 640 citations
  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
  Nancy E. Kemeny, Ying Huang, Alfred M. Cohen, Weiji Shi, John A. Conti, Murray F. Brennan, Joseph R. Bertino, Alan D. Turnbull, Deidre Sullivan, J. Stockman, Leslie H....> ;The New England Journal of Medicine. 1999 Dec 30
• 8 citations
  Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
  T. B. Clark, Nancy E. Kemeny, John A. Conti, Ying Huang, A. M. Andre, J. Stockman> ;Cancer Investigation. 1998 Jan 1
• 134 citations
  Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer
  Bruce D. Minsky, Alfred M. Cohen, Warren E. Enker, Leonard B. Saltz, Philip B. Paty, David P. Kelsen, Nancy E. Kemeny, David H. Ilson, Joanne Bass, John A. Conti, Jose...> ;International Journal of Radiation Oncology, Biology, Physics. 1997 Jan 15
• 286 citations
  Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
  John A. Conti, Nancy E. Kemeny, Leonard B. Saltz, Ying Huang, William P. Tong, Ting-Chao Chou, Ming Sun, S. Pulliam, C. Gonzalez> ;Journal of Clinical Oncology. 1996 Mar 1
• 6 citations
  Cancer chemotherapy in the elderly.
  J A Conti, Karen L. Christman> ;Journal of Clinical Gastroenterology. 1995 Jul 1
• 125 citations
  RELATIONSHIP OF ACUTE GASTROINTESTINAL TOXICITY AND THE VOLUME OF IRRADIATED SMALL BOWEL IN PATIENTS RECEIVING COMBINED MODALITY THERAPY FOR RECTAL CANCER
  Bruce D. Minsky, John A. Conti, Ying Huang, Kevin B. Knopf> ;Journal of Clinical Oncology. 1995 Jun 1
• 18 citations
  Continuous infusion fluorouracil/leucovorin and bolus mitomycin‐C as a salvage regimen for patients with advanced colorectal cancer
  John A. Conti, Nancy E. Kemeny, Leonard B. Saltz, A. McKenzie André, Dennis D. Grossano, Joseph R. Bertino> ;Cancer. 1995 Feb 1
• 84 citations
  A fixed-ratio combination of uracil and ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer
  Leonard B. Saltz, Cynthia G. Leichman, Charles W. Young, Franco M. Muggia, John A. Conti, B A Tara Spiess, R N Susan Jeffers, Lawrence P. Leichman> ;Cancer. 1995 Feb 1
• 122 citations
  Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
  Nancy E. Kemeny, John A. Conti, Alfred M. Cohen, P. Campana, Ying Huang, Wei Ji Shi, Jose Botet, S. Pulliam, Joseph R. Bertino> ;Journal of Clinical Oncology. 1994 Nov 1
• 3 citations
  Chemotherapy for colorectal cancer.
  Nancy E. Kemeny, John A. Conti, Joseph R. Bertino> ;The New England Journal of Medicine. 1994 Sep 8
• 9 citations
  Colon carcinoma metastatic to the trachea: Report of a case and a review of the literature
  John A. Conti, Nancy E. Kemeny, David S. Klimstra, Bruce D. Minsky, Valerie W. Rusch> ;American Journal of Clinical Oncology. 1994 Jun 1
• 34 citations
  Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
  John A. Conti, Nancy E. Kemeny, Karen Seiter, Erdem Goker, William P. Tong, McKenzie André, Karen Ragusa, Joseph R. Bertino> ;Journal of Clinical Oncology. 1994 Apr 1
• 78 citations
  Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
  Nancy Kemeny, Karen Seiter, John A. Conti, Alfred M. Cohen, Joseph R. Bertino, Elin R. Sigurdson, Jose Botet, Douglass Chapman, Madhu Mazumdar, J B A Andrew Budd> ;Cancer. 1994 Feb 15
• 107 citations
  Preoperative 5‐fluorouracil, low‐dose leucovorin, and concurrent radiation therapy for rectal cancer
  Bruce Minsky, Alfred M. Cohen, Warren Enker, David Kelsen, Nancy Kemeny, David Ilson, Leonard Saltz, R N Joanne Frankel, John Conti, Jose Guillem> ;Cancer. 1994 Jan 15
• 42 citations
  A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic me...
  Nancy Kemeny, John A. Conti, Elin Sigurdson, Alfred M. Cohen, Karen Seiter, Robert Lincer, Donna Niedzwiecki, Jose Botet, Douglass Chapman, R N Patricia Costa, B S And...> ;Cancer. 1993 Mar 15
• 58 citations
  Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorect...
  Nancy E. Kemeny, Alfred M. Cohen, Karen Seiter, John A. Conti, Elin R. Sigurdson, Yue Tao, Donna Niedzwiecki, Jose Botet, A. Budd> ;Journal of Clinical Oncology. 1993 Feb 1
• 52 citations
  Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating facto...
  John A. Conti, Howard I. Scher> ;Cancer. 1992 Dec 1
• 19 citations
  Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.
  Nancy E. Kemeny, John A. Conti, Karen Seiter, Donna Niedzwiecki, Jose Botet, Daniel Martin, Patricia Costa, Jill Wiseberg, William McCulloch> ;Journal of Clinical Oncology. 1992 May 1
• 18 citations
  Type la glycogenosis associated with hepatocellular carcinoma
  John A. Conti, Nancy E. Kemeny> ;Cancer. 1992 Mar 15
• Join now to see all

Journal Articles

• Hepatio Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer.  
  Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, et al, N Engl J Med, 1/1/1999
• Phase II Trial of Docetaxel (Taxotere) for Untreated Advanced Colorectal Carcinoma.  
  Clark TB, Kemeny NE, Conti JA, et al, Cancer Invest, 1/1/1998
• Site Specific Study: Breast Cancer -DCIS.  
  Conti JA, Arani I, Mountainside Hospital Cancer Program Annual Report, 1/1/1998
• Preoperative 5-FU, Low-Dose Leucovorin, and Radiation Therapy for Locally Advanced and Unresectable Rectal Cancer.  
  Minsky BD, Cohen AM, Enker WE, Conti J, Int J Radiat Oncol Biol Phys, 1/1/1997
• Irinotecan (CPT-11) is an Active Agent in Untreated Patients with Metastatic Colorectal Cancer.  
  Conti JA, Kemeny NE, Saltz LB, Hunag Y, et al, J Clin Oncol, 1/1/1996
• Acute Toxicity of Neoadjuvant Bolus 5-FU and Followed by Continuous Infusion 5-FU Plus Pre-Operative Radiaition Therapy for Rectal Cancer.  
  Minsky B, Conti J, Cohen A, Kelsen D, et al, Radiat Oncol Invest, 1/1/1996
• Cancer chemotherapy in the elderly.  
  Conti JA, Christman K, J Clin Gastroenterol, 1/1/1995
• Continuous Infusion Fluorouracil/Leucovorin and Bolus Mitomycin-C as a Salvage Regimen in Advanced Colorectal Cancer.  
  Conti JA, Kemeny N, Saltz L, et al, Cancer, 1/1/1995
• A Fixed-Ratio Combination of Uracil and Ftorafur(UFT) and Low Dose Leucovorin: An Active Oral Regimen for Advanced Colorectal Cancer.  
  Saltz L, Leichman CG, Young CW, Muggia FM, Conti JA, et al, Cancer, 1/1/1995
• Relationship of Acute Gastrointestinal Toxicity and the Volume of Irradiated Small Bowel in Patients Receiving Combined Modality Therpay for Rectal Cancer.  
  Minsky B, Conti J, Huang Y, Knoph K, J Clin Oncol, 1/1/1995
• A Comparison of Umbilical Cord Blood Gas Values betwen Newborns with and without True Knots.  
  Maher JT, Conti JA, Hawkes GG, Obstet Gynecol, 1/1/1995
• Colon carcinoma metastatic to the trachea: Report of a case and a review of the literature.  
  Conti JA, Kemeny N, Klimstra D, Am J Clin Oncol, 1/1/1994
• Hereditary spherocytosis and hematologic malignancy.  
  Conti JA, Howard LM, NJ Med, 1/1/1994
• Pre-operative 5-Fluorouracil, low dose leucovorin, and concurrent radiation therapy for rectal cancer.  
  Minsky B, Cohen A, Enker W, Conti J, Cancer, 1/1/1994
• Hepatic Arterial FUDR and Leucovorin for Unresectable Liver Metastases from Colorectal Carcinoma: New Dose Schedules and Survival Update.  
  Kemeny N, Seiter K, Conti JA, et al, Cancer, 1/1/1994
• Trial of Sequential Trimetrexate, Fluorouracil and High-Dose Leucovorin in Previously Treated Patients with Gastrointestinal Carcinoma.  
  Conti JA, Kemeny N, Seiter K, et al, J Clin Oncol, 1/1/1994
• Commentary on - "Chemoembolization of Hepatic Malignancies".  
  Conti JA, Kemeny N, Oncology, 1/1/1994
• A Phase II Study of Hepatic Arterial FUDR, Leucovorin, and Dexamethasone for Unresectable Liver Metastases from Colorectal Carcinoma.  
  Kemeny N, Conti JA, Cohen A, et al, J Clin Oncol, 1/1/1994
• Chemotherapy for Colorectal Cancer.  
  Kemeny NE, Conti JA, Bertino JR, N Engl J Med, 1/1/1994
• A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin: A potential adjuvant program after resection of colorectal hepatic me...  
  Kemeny N, Conti JA, Sigurdson E, et al, Cancer, 1/1/1993
• A randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colore...  
  Kemeny N, Conti JA, Sigurdson E, et al, J Clin Oncol, 1/1/1993
• Case Report: Type la glycogenosis associated with hepatocellular carcinoma.  
  Conti JA, Kemeny N, Cancer, 1/1/1992
• Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.  
  Kemeny N, Conti JA, Seiter K, et al, J Clin Oncol, 1/1/1992
• Acute arterial thrombosis after escalated dose methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy with recombinant granulocyte colony-stimulatin...  
  Conti JA, Scher HI, Cancer, 1/1/1992
• Seventeen ways to help you survive your residency.  
  Conti JA, Residents' Forum in Internal Medicine, 11/1/1990
• Join now to see all

Books/Book Chapters

• Cancer of the Colon, Rectum, and Anus 
  Chapter: Metastatic Colorectal Cancer: Are There Prognostic Determinants. 
  Page 769 - 781Conti JA, Kemeny NEditors: Cohen AM, Winawer SJ.McGraw-Hill, Inc., New York, NY.1995

Abstracts/Posters

• Treatment with Gemcitabine (GEM) for Patients with Advanced Pancreatic Cancer in a Community Oncology Practice.
  Conti JA, Scoppetuolo M, Alter RS, et al, Clinical Cancer Research in NJ, 3/5/1997
• Final Results of a Phase I Trial of Sequential Trimetrexate (TMTX), Fluorouracil (FU), and High Dose Leucovorin (LV) in Previously Treated Patients (Pts) with Gastroin...
  Conti JA, Kemeny NE, Tong W, Andre M, Bertino JR, Proc Am Soc Clin Oncol, 1/1/1997
• Experience with Trimetrexate in GI Cancer.
  Conti JA, J Clin Invest Chemotherapy, 1/1/1995
• Triacetyluridine(TAU) as Rescue for 5-Fluorouracil (FU) Allows Increased FU Dose Intensity When Given with N-Phosphonacetyl-L-Aspartate (PALA) and Methotrexate (MTX) i...
  Conti JA, Kemeny N, Kelly J, Gonzalez C, Bertino J, Martin D, Proc Am Soc Clin Oncol, 1/1/1995
• Relationship of Acute Gastrointestinal Toxicity and the Volume of Irradiated Small Bowel in Patients Receiving Combined Modality Therpay for Rectal Cancer.
  Minsky B, Conti J, Huang Y, Knoph K, Proc Am Soc Clin Oncol, 1/1/1995
• Hepatic Arterial Infusion of Floxuridine (FUDR), Dexamethasone (Dex) and High Dose Mitomycin C (Mit C): Comparable Response to FUDR/ Leucovorin/Dex but with Greater To...
  Kemeny N, Conti JA, Blumgart L, et al, Proc Am Soc Clin Oncol, 1/1/1995
• Molecular Radiotherapy of Hepatic Metastases from Colorectal Cancer (CA) using Hepatic Arterial I-131/I-125-Iododeoxyuridine (IUdR).
  Macapinlac H, Kemeny N, Daghighian F, Conti J, et al, Proc Am Soc Clin Oncol, 1/1/1995
• Phase I Trial of Irinotecan (CPT-11), 5-Fluorouracil (FU), and Leucovorin (LV) in Patients with Advanced Solid Tumors.
  Saltz L, Kanowitz J, Kemeny N, Kelsen D, Conti J, et al, Proc Am Soc Clin Oncol, 1/1/1995
• Irinotecan (CPT-11) is an active agent in untreated patients (pts) with metastatic colorectal cancer (CRC).
  Conti JA, Kemeny N, Saltz L, Tong W, Chou TC, Pulliam M, et al, Proc Am Soc Clin Oncol, 1/1/1994
• Phase ll Trial of Docetaxel (Taxotere, RP56976) in Previously Untreated Patients (pts) with Advanced Colorectal Cancer (CRC).
  Clark T, Kemeny N, Conti JA, Andre M, Proc Am Soc Clin Oncol, 1/1/1994
• Combined Modality Therapy of Rectal Cancer: Past Results and Future Directions.
  Conti JA, Kemeny N, Minsky BD, J Infus Chemo, 1/1/1994
• Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen in advanced colorectal carcinoma.
  Conti JA, Kemeny N, Bertino J, et al, Proc Am Soc Clin Res, 1/1/1993
• A phase l trial of sequential trimetrexate, fluorouracil and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
  Conti JA, Kemeny N, Goker E, et al, Proc Am Soc Clin Oncol, 1/1/1993
• Long term survival in patients with hepatic metastases from colorectal cancer treated with continuous intrahepatic infusion of floxuridine and leucovorin via an infusa...
  Kemeny N, Conti JA, Seiter K, et al, Proc Am Soc Clin Oncol, 1/1/1993
• Pre-operative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer.
  Minsky B, Cohen A, Enker W, Conti J, Proc Am Soc Clin Oncol, 1/1/1993
• Phase l and clinical pharmacologic studies of oral UFT alone and with oral leucovorin.
  Saltz L, Young C, Currie V, Tong W, Conti J, et al, Proc Am Soc Clin Oncol, 1/1/1993
• A Phase I-II trial of Phosphonacetyl-L-Aspartic Acid (PALA) and 5-fluorouracil (FU) in metastatic colorectal carcinoma with oral uridine (UR) as a rescue agent for FU.
  Kemeny N, Conti JA, Martin D, et al, Proc Am Soc Clin Oncol, 1/1/1992
• A Phase I trial of hepatic artery fluorodeoxyuridine (FUDR) with systemic 5-fluorouracil (FU) and leucovorin (LV) as adjuvant therapy after colorectal carcinoma hepati...
  Kemeny N, Conti JA, Seiter K, et al, Proc Am Soc Clin Oncol, 1/1/1992
• Join now to see all